Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 17, 2024 Bullish $29.58 V 0
Aug 28, 2024 $30.18 +4.77% $26.71 X 87.00% 0
Aug 28, 2024 $29.67 +2.98% $26.71 X 88.92% 0
Aug 28, 2024 Bullish $26.71 X 0
May 20, 2024 $22.56 -2.41% $22.10 V 97.88% 1
May 20, 2024 $22.77 -1.51% $22.10 V 96.94% 1
May 20, 2024 Bullish $22.10 V 0
May 9, 2024 $22.06 +2.29% $21.11 X 95.48% 0
May 9, 2024 $21.88 +1.43% $21.11 X 96.36% 0
thedean2010 thedean2010 Merchant
May 9, 2024 Bullish $21.11 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE